Epithelial ovarian cancer (EOC) remains the most lethal gynecological malignancy worldwide, primarily due to late-stage diagnosis, limited early screening tools, and the aggressive nature of the disease. Increasing global efforts have been directed toward harmonizing clinical guidelines and ensuring equitable access to optimal care. This narrative review provides a comprehensive overview and critical comparison of the most recent international guidelines for ovarian cancer management, emphasizing similarities and discrepancies. Each section examines diagnostic, surgical, and therapeutic recommendations across all disease stages—from prevention to recurrence. Emerging advances that are reshaping the management of EOC such as preclinical models and the application of artificial intelligence are also discussed. This work provides an updated and practical synthesis to support clinicians, researchers, and policymakers in optimizing ovarian cancer management and guiding future research priorities in precision oncology.
上皮性卵巢癌（EOC）仍是全球致死率最高的妇科恶性肿瘤，主要归因于其诊断时多已进展至晚期、早期筛查手段有限以及疾病本身具有侵袭性。全球范围内正不断加强努力，以协调临床指南并确保患者公平获得最佳诊疗。本文通过叙述性综述，全面概述并批判性比较了最新的国际卵巢癌管理指南，重点分析其异同点。各部分详细探讨了从预防到复发等各疾病阶段的诊断、手术及治疗建议，同时讨论了正在重塑EOC管理格局的新进展，如临床前模型和人工智能的应用。本综述提供了最新且实用的整合分析，旨在为临床医生、研究人员及政策制定者优化卵巢癌管理、指导精准肿瘤学未来研究方向提供支持。
肿瘤(癌症)患者之家